Patterns Of Care, Survival, and Costs Of Second-Line Treatment In Medicare Beneficiaries With Diffuse Large B-Cell Lymphoma (DLBCL)

被引：2
|
作者：
Danese, Mark
Griffiths, Robert
Gleeson, Michelle
Dalvi, Tapashi
Li, Jingyi
Deeter, Robert G.
Mikhael, Joseph R.
Dreyling, Martin
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2936.2936
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2936
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The effect of diffuse large B-cell lymphoma (DLBCL) treatment regimens on survival: A prospective cohort study
    Sieniawski, M.
    Mainou-Fowler, T.
    Wilkinson, J.
    Culligan, D.
    Davison, J.
    Goodlad, J. R.
    Jackson, G.
    Lucraft, H.
    Lewis, J.
    Lennard, A.
    McKay, P.
    Miekeljohn, D.
    Prescott, R.
    White, J.
    Proctor, S. J.
    ANNALS OF ONCOLOGY, 2008, 19 : 216 - 216
  • [22] Second-line Treatment With CAR T-Cell Therapy for Large B-Cell Lymphoma
    Lutfi, Forat
    Patel, Ameet
    Mehta, Jasmine
    Goyal, Anmol
    Dahiya, Saurabh
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (04) : 170 - 178
  • [23] Patient preferences for second-line treatment options in diffuse large B-cell lymphoma: A discrete choice experiment.
    Birch, Kelly
    Chiu, Kevin
    Baumgardner, James
    Snider, Julia
    Wade, Sally West
    Shah, Gunjan L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): CURRENT AND FUTURE TREATMENT STRATEGIES
    Antonio De Souza, Carmino
    LEUKEMIA RESEARCH, 2015, 39 : SS8 - SS8
  • [25] Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
    Locke, F. L.
    Miklos, D. B.
    Jacobson, C. A.
    Perales, M-A
    Kersten, M-J
    Oluwole, O. O.
    Ghobadi, A.
    Rapoport, A. P.
    McGuirk, J.
    Pagel, J. M.
    Munoz, J.
    Farooq, U.
    van Meerten, T.
    Reagan, P. M.
    Sureda, A.
    Flinn, I. W.
    Vandenberghe, P.
    Song, K. W.
    Dickinson, M.
    Minnema, M. C.
    Riedell, P. A.
    Leslie, L. A.
    Chaganti, S.
    Yang, Y.
    Filosto, S.
    Shah, J.
    Schupp, M.
    To, C.
    Cheng, P.
    Gordon, L., I
    Westin, J. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07): : 640 - 654
  • [26] Trends in the improvement in survival among patients with diffuse large B-cell lymphoma (DLBCL)
    MacDougall, Kira
    Day, Silas
    Nipp, Ryan David
    Hall, Spencer
    Zhao, Yan D.
    Al-Juhaishi, Taha
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 147 - 147
  • [27] Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
    Bishop, M. R.
    Dickinson, M.
    Purtill, D.
    Barba, P.
    Santoro, A.
    Hamad, N.
    Kato, K.
    Sureda, A.
    Greil, R.
    Thieblemont, C.
    Morschhauser, F.
    Janz, M.
    Flinn, I
    Rabitsch, W.
    Kwong, Y-L
    Kersten, M. J.
    Minnema, M. C.
    Holte, H.
    Chan, E. H. L.
    Martinez-Lopez, J.
    Mueller, A. M. S.
    Maziarz, R. T.
    McGuirk, J. P.
    Bachy, E.
    Le Gouill, S.
    Dreyling, M.
    Harigae, H.
    Bond, D.
    Andreadis, C.
    McSweeney, P.
    Kharfan-Dabaja, M.
    Newsome, S.
    Degtyarev, E.
    Awasthi, R.
    del Corral, C.
    Andreola, G.
    Masood, A.
    Schuster, S. J.
    Jaeger, U.
    Borchmann, P.
    Westin, J. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07): : 629 - 639
  • [28] Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma
    Tsutsue, Saaya
    Tobinai, Kensei
    Yi, Jingbo
    Crawford, Bruce
    PLOS ONE, 2020, 15 (08):
  • [29] TREATMENT PATTERNS AND COSTS ASSOCIATED WITH DIFFUSE LARGE B-CELL LYMPHOMA A RETROSPECTIVE ANALYSIS OF CLAIMS
    Garcia, J.
    Gitlin, M.
    Snyder, S.
    McMorrow, D.
    Bonafede, M. M.
    Tkacz, J.
    VALUE IN HEALTH, 2018, 21 : S26 - S27
  • [30] Treatment, HSCT Patterns, and Survival of Elderly Diffuse Large B-Cell Lymphoma Patients in the SEER-Medicare Linked Database
    Shaw, Jaime
    Johns, Lauren
    Harvey, Christopher
    Richards, Catherine
    Kim, Christopher
    BLOOD, 2018, 132
12345